Intent to Sole Source Qiagen Rotor-Gene Q 5plex Cycler

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Qiagen LLC for a Rotor-Gene Q 5plex Platform and RGQ, IQ/OQ Service. The Qiagen Rotor-Gene Q 5plex cyclers are the most popular real-time PCR equipment in the European region, with over 160 WHO-supported polio diagnostic labs using them. Use of the Qiagen Rotor-Gene Q 5plex Platform is a requirement of the WHO for a reference laboratory to be able to evaluate the performance of the standardized molecular assays for Poliovirus detections and typing. The Qiagen Rotor-Gene Q Platform is designed significantly differently in comparison to other real-time machines in the market. It has a unique centrifugal rotary design with a rotor that spins the samples. Heating/cooling is achieved by rapid airflow in the reaction chamber. No other machine can replace the Rotor-Gene Q Platform due to its unique design.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at email@cdc.gov by 11:00EDT August 2, 2024.